Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapyMark Brantly, Terence R. Flotte, Margaret Humphries et al.|Proceedings of the National Academy of Sciences|2009Cited by 322
Clinical Evaluation of a Recombinant Adeno-Associated Virus (rAAV) Alpha-1 Antitrypsin (AAT) Gene Therapy Vector.Jeff Chulay, Terence R. Flotte, Mark Brantly et al.|Unknown|2009Cited by 0